3 assets in Chromosome 17p Deletion

Therapeutic assets addressing Chromosome 17p Deletion, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dexasone Chromosome 17p Deletion	Fondazione EMN Italy Onlus	P2	BB (67)
Daratumumab Chromosome 17p Deletion	Fondazione EMN Italy Onlus	P2	CCC (53)
Pomalidomide Chromosome 17p Deletion	Fondazione EMN Italy Onlus	P2	CCC (53)